Potential use of decorin in preventing cerebral vasospasm through the inhibition of transforming growth factor-beta activity: Insights from an experimental rabbit subarachnoid hemorrhage model
| dc.contributor.author | Yaman, Betul | |
| dc.contributor.author | Gel, Gulce | |
| dc.contributor.author | Tuncer, Cengiz | |
| dc.contributor.author | Hanalioglu, Sahin | |
| dc.contributor.author | Bulut, Husamettin | |
| dc.contributor.author | Arikök, Ata Türker | |
| dc.contributor.author | Gürer, Bora | |
| dc.date.accessioned | 2025-10-11T20:45:21Z | |
| dc.date.available | 2025-10-11T20:45:21Z | |
| dc.date.issued | 2025 | |
| dc.department | Düzce Üniversitesi | en_US |
| dc.description.abstract | Objective: The development of vasospasm after subarachnoid hemorrhage (SAH) is a major cause of death and disability. It leads to structural changes such as smooth muscle and myofibroblast proliferation, necrosis, intimal hyperplasia, and vascular fibrosis. Transforming growth factor-beta1 (TGF-β1) activates nonmuscular myofibroblasts, promoting cerebral vasoconstriction. Decorin, a natural TGF-β inhibitor, has not yet been evaluated for its potential to prevent SAH-induced vasospasm. This study aimed to investigate the effects of decorin on cerebral vasculopathy and hippocampal injury in a rabbit model of TGF-β-induced vasospasm. Methods: Thirty-two male New Zealand white rabbits (2.5–4 kg) were randomly assigned to four groups: control, SAH, decorin, and TGF-β1. Except for the control group, all underwent the SAH procedure. The decorin group received 100 μg/kg decorin intraperitoneally for 3 days; the TGF-β1 group received 50 μg TGF-β1 intracisternally in 1 cc autologous CSF. Animals were sacrificed at 72 h using perfusion–fixation. Basilar artery cross-sectional area, wall thickness, and hippocampal degeneration scores were assessed using histopathological and statistical analysis systems. Results: Based on statistical analyses, decorin treatment significantly increased the cross-sectional area of the basilar artery but significantly reduced the wall thicknesses compared with those in the SAH and TGF-β1 groups. Furthermore, hippocampal neuronal degeneration scores were significantly lower in the decorin and control groups than in the SAH and TGF-β1 groups. There were no significant differences between the groups in terms of proliferating cell nuclear antigen. Conclusion: Decorin treatment in rabbits with experimentally induced SAH ameliorated TGF-β1-induced vasospasm, cerebral vasculopathy associated with vascular wall fibrosis, and subsequent decreased vessel wall thickness. © 2025 Elsevier B.V., All rights reserved. | en_US |
| dc.identifier.doi | 10.1016/j.wnsx.2025.100520 | |
| dc.identifier.issn | 2590-1397 | |
| dc.identifier.scopus | 2-s2.0-105016513800 | en_US |
| dc.identifier.scopusquality | Q2 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.wnsx.2025.100520 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12684/21312 | |
| dc.identifier.volume | 28 | en_US |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Inc. | en_US |
| dc.relation.ispartof | World Neurosurgery: X | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.snmz | KA_Scopus_20250911 | |
| dc.subject | Cerebral Arteries | en_US |
| dc.subject | Decorin | en_US |
| dc.subject | Hippocampus | en_US |
| dc.subject | Rabbit | en_US |
| dc.subject | Subarachnoid Hemorrhage | en_US |
| dc.subject | Tgf-β1 | en_US |
| dc.subject | Vasospasm | en_US |
| dc.subject | Cycline | en_US |
| dc.subject | Decorin | en_US |
| dc.subject | Transforming Growth Factor Beta1 | en_US |
| dc.subject | Animal Cell | en_US |
| dc.subject | Animal Experiment | en_US |
| dc.subject | Animal Model | en_US |
| dc.subject | Animal Tissue | en_US |
| dc.subject | Arterial Wall Thickness | en_US |
| dc.subject | Article | en_US |
| dc.subject | Basilar Artery | en_US |
| dc.subject | Brain Vasospasm | en_US |
| dc.subject | Cell Proliferation | en_US |
| dc.subject | Controlled Study | en_US |
| dc.subject | Hippocampus | en_US |
| dc.subject | Histopathology | en_US |
| dc.subject | Male | en_US |
| dc.subject | Nerve Cell Degeneration | en_US |
| dc.subject | New Zealand White (rabbit) | en_US |
| dc.subject | Nonhuman | en_US |
| dc.subject | Sectional Anatomy | en_US |
| dc.subject | Subarachnoid Hemorrhage | en_US |
| dc.title | Potential use of decorin in preventing cerebral vasospasm through the inhibition of transforming growth factor-beta activity: Insights from an experimental rabbit subarachnoid hemorrhage model | en_US |
| dc.type | Article | en_US |












